Eli Lilly Corp. buy UBS Group AG
Start price
20.10.23
/
50%
€557.00
Target price
20.10.24
€670.67
Performance (%)
27.94%
Price
16:35
€709.20
Summary
This prediction is currently active. The prediction currently has a performance of 27.94%. A total of €3.44 was paid as dividends for this prediction. This prediction currently runs until 20.10.24. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Eli Lilly Corp. | -1.169% | -1.169% |
iShares Core DAX® | -0.051% | 4.829% |
iShares Nasdaq 100 | 1.659% | 2.417% |
iShares Nikkei 225® | 0.658% | -2.173% |
iShares S&P 500 | 0.964% | 2.547% |
Comments by UBS_Group_AG for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE: LLY) had its "buy" rating re-affirmed by analysts at UBS Group AG. They now have a $710.00 price target on the stock, up previously from $612.00.
Ratings data for LLY provided by MarketBeat